ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
0.9601
-0.0399 (-3.99%)
At close: Sep 4, 2026, 4:00 PM EDT
0.95685
-0.0032 (-0.33%)
After-hours: Sep 4, 2026, 7:30 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $24.89 million as of September 4, 2026. Its market cap has decreased by -60.99% in one year.
Market Cap
24.89M
Enterprise Value
27.68M
1-Year Change
-60.99%
Ranking
Category
Stock Price
$0.96
ChartMarket Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $24.89M, a decrease of -68.69%. That is a compound annual growth rate of -20.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 25.60M | -50.58% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 25.21M |
| Atossa Therapeutics | 25.09M |
| Palatin Technologies | 24.70M |
| Quantum BioPharma | 24.05M |
| Lantern Pharma | 23.78M |
| Allarity Therapeutics | 22.83M |
| Jasper Therapeutics | 22.80M |
| Polyrizon | 22.74M |